CLN3 lysosomal/endosomal transmembrane protein, battenin
| GO Term | Evidence Code | PMID |
|---|---|---|
| action potential | ||
| positive regulation of protein phosphorylation | ||
| protein phosphorylation | ||
| amino acid transport | ||
| endocytosis |
| GO Term | Evidence Code | PMID |
|---|---|---|
| Golgi membrane | ||
| Golgi membrane | ||
| nucleus | ||
| nucleus | ||
| cytoplasm |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding | ||
| calcium-dependent protein binding | ||
| glycolipid binding | ||
| glycolipid binding | ||
| sulfatide binding |
| Gene Ontology |
|---|
| lysosomal lumen acidification |
| InterPro |
|---|
| Batten's disease protein Cln3, subgroup |
| Batten's disease protein Cln3 |
| MFS transporter superfamily |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110731 | neuronal ceroid lipofuscinosis 3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025